India forms task force for research & development of COVID-19 vaccine
Category: #health  By Saipriya Iyer  Date: 2020-04-20
  • share
  • Twitter
  • Facebook
  • LinkedIn

India forms task force for research & development of COVID-19 vaccine

India has recently formed a high-level task force to focus on the research and development of the coronavirus vaccine. Additionally, this task force will also coordinate with various international communities to surge the COVID-19 vaccine development process.

The task force will be reportedly co-chaired by Niti Aayog, Member, and Professor K VijayRaghavan, Principal Scientific Adviser, Govt. of India. According to the Joint Secretary, Ministry of Health and Family Welfare, Lav Agarwal, members of the recent task force reportedly include Drug Controller General of India, DG-Health Services, DRDO, CSIR, DBT (Department of Biotechnology), DST (Department of Science & Technology), ICMR, and AYUSH.

Mr. Agarwal further added that DBT has been appointed as the central coordinating authority of the task force, with the main aim of initiating the process of vaccine development. It will also monitor the progress of the research as well as facilitate the development process. Additionally, the task force will list down various international and national organizations that are part of the development of the vaccine.

Nearly 70 clinical trials for the COVID-19 vaccine are in development globally, out of which, 5 have entered the human trial phase. Various Indian companies such as Biological E, Bharat Biotech, Zydus Cadila, and Serum Institute are currently in the preclinical stage.

This task force will develop the clinical cohorts that focus on the long-term follow up of people to ensure a deep understanding of the COVID-19 disease. The bio-specimens collected will form the basis for further clinical trials of vaccines and drugs. This will reportedly be different from the sample testing protocols.

3,86,791 coronavirus tests have been performed in total till date, out of which, 37,173 tests were conducted recently. In India, the pandemic has infected 16,116 patients and claimed the lives of 519 people, with 2,301 people having recovered from the disease. 1,006 new infected cases and 31 deaths have been reported in the last 24 hours.

Source credit:

https://www.businesstoday.in/sectors/pharma/india-sets-up-high-level-task-force-to-develop-vaccine-for-coronavirus-to-co-ordinate-with-global-researchers/story/401424.html



About Author

Saipriya Iyer

Email: [email protected]   

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

Read More

More News By Saipriya Iyer

AdaptHealth enters definitive deals to acquire Solara & ActivStyle
AdaptHealth enters definitive deals to acquire Solara & ActivStyle
By Saipriya Iyer

AdaptHealth Corp. has recently entered two separate definitive agreements for the acquisition of Solara Medical Supplies, LLC and ActivStyle, Inc. AdaptHealth is a leading home medical supplies, equipment, and other re...

Ambani’s JioMart unveils a new website to deliver orders across India
Ambani’s JioMart unveils a new website to deliver orders across India
By Saipriya Iyer

Jio Platforms, the top telecom operator along with Jio Retail, which is the top retail chain has recently unveiled JioMart’s new website and has begun taking orders in a large amount from tier 1, tier 2 and metro c...

Omada enters $30M acquisition deal with digital health company Physera
Omada enters $30M acquisition deal with digital health company Physera
By Saipriya Iyer

Omada Health, which has raised nearly $57 million in funding, has reportedly acquired a digital health company, Physera. It provides remote physical therapy to its customers.

The co...